IN THIS ISSUE

Q&A
The CMO of Blue Cross and Blue Shield of Minnesota is hopeful that the goal of true population management is near.
MargaretAnn Cross
Although plans are not restructuring fee schedules in consumer-directed health plans, providers think their agreements need fine-tuning.
Peer-Reviewed
David W. Dodick, MD
Robert J. Lipsy, PharmD
In response to the expense of new migraine therapies, treatment practices aimed at controlling direct costs are now the norm.
Legislation & Regulation
John Carroll
Despite the focus on the international situation, Americans are still keenly interested in just how they'll get the medical care they need.
Employer Update
MargaretAnn Cross
Sure, there may be some costs up front, but there is also an opportunity for health plans to profit as employers' concern about this issue grows.
Tomorrow's Medicine
Thomas Morrow, MD
When traditional therapies fail in cancer treatment, turning off a chemical switch may offer hope to the hopeless.
News and Commentary
News and Commentary